Effects of stool dilution on the faecal Helicobacter pylori antigen test

T Shimizu1, T Fujii, H Haruna

  • 1Department of Pediatrics, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. tsimizut@aol.com

Insights

Diluting stool samples for the faecal Helicobacter pylori antigen test generally yields accurate results up to a 1:10 dilution. Higher dilutions, like 1:50, may lead to false negatives, even with low antigen levels.

Area of Science:

  • Gastroenterology
  • Microbiology
  • Diagnostic Testing

Background:

  • Helicobacter pylori infection is a significant cause of gastrointestinal diseases.
  • Accurate detection of H. pylori is crucial for effective treatment.
  • The faecal antigen test is a common diagnostic method, but its performance can be affected by sample preparation.

Purpose of the Study:

  • To evaluate the impact of stool sample dilution on the sensitivity and specificity of the faecal H. pylori antigen test.
  • To determine the optimal dilution threshold for reliable H. pylori antigen detection in stool.

Main Methods:

  • Stool samples from nine H. pylori-infected children were analyzed.
  • Samples were serially diluted with normal saline (1:1, 1:5, 1:10, 1:50, 1:100, 1:500).
  • Optical density (OD) was measured to quantify antigen levels and assess test results at each dilution.

Main Results:

  • The faecal H. pylori antigen test remained positive for all samples diluted 1:10 or less.
  • One sample with initially low OD values transitioned from positive to negative at a 1:50 dilution.
  • This indicates a potential for false-negative results at higher dilutions.

Conclusions:

  • Stool dilutions of 1:10 or less are generally reliable for the faecal H. pylori antigen test.
  • Higher dilutions (e.g., 1:50) may increase the risk of false-negative results, particularly in cases with low initial antigen levels.
  • Careful consideration of sample dilution is recommended for accurate H. pylori diagnosis.
Abstract

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...